Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+67.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+67.2%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.7x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$5918.00-
2024$0.00-
2023$0.00-100.0%
2022$1266.00-